1. OC-0323: Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer. (April 2018) Authors: De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; Colombo, A.; Fyles, A.; Baron, M.H.; Jürgenliemk-Schulz, I.M.; Kitchener, H.C.; Nijman, H.W.; Wilson, G.; Kolodziej, I.; Carinelli, S.; Lutgens, L.C.H.W.; Smit, V.T... Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3. (November 2020) Authors: Post, C.; De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; D'Amico, R.; Fyles, A.; Baron, M.; Kitchener, H.C.; Nijman, H.W.; Lutgens, L.C.; Brooks, S.; Jürgenliemk-Schulz, I.M.; Feeney, A.; Nout, R.A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗